SI-Bone(SIBN)
$23.75+0.21 (+0.89%)
SIBN
SI-Bone stock drug pipeline
$23.75
At close:+0.21 (+0.89%)
Want to see SIBN full AI Analyst Report?
SI-Bone (SIBN) Drug Pipeline
191 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Use Of Ifuse Torq | Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain, Sacroiliac; Fusion, Sacroiliac Disorder | Phase IV | Active Not Recruiting | iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction | May 12, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Use Of Ifuse Torq | Phase IV | Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain, Sacroiliac; Fusion, Sacroiliac Disorder | Active Not Recruiting | iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction | May 12, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Si-Bone (SIBN) have in its pipeline
SI-Bone SIBN is currently developing the following drugs: Use Of Ifuse Torq. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

